NI
SYRS

Numeric Investors’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Numeric Investors’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-5,481
Closed -$807K – 1209
2017
Q3 		$807K Buy
+5,481
New +$1.03M 0.01% 795

Other funds holding SYRS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Numeric Investors's SYRS Position: Q4 2017 in Review

Numeric Investors sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q4 2017, closing a stake of 5,481 shares — an estimated $807K sold.

Numeric Investors first reported a position in SYRS in Q3 2017 and held it in 1 quarter. The position peaked at $807K in Q3 2017. 69 funds tracked by Wall St. Rank hold SYRS as of Q4 2017.

  • Numeric Investors reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Numeric Investors sold 5,481 Syros Pharmaceuticals, Inc. Common Stock shares in Q4 2017, an estimated $807K.
  • Numeric Investors first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 1 quarter.
  • Numeric Investors's Syros Pharmaceuticals, Inc. Common Stock position peaked at $807K in Q3 2017.
  • 69 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.